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Abstract
Background: Normal-looking skin of dogs with leishmaniosis frequently shows microscopic lesions along with the
presence of Leishmania amastigotes. However, histological lesions with or without detection of amastigotes might
not occur in less severe clinical cases. In addition, comparative studies between paired clinically-lesioned and normal-
looking skin samples from dogs with different disease severity are lacking. The objective of this study was to compare
histological and parasitological findings by Leishmania immunohistochemistry (IHC) and quantitative PCR (qPCR) on
paired clinically-lesioned and normal-looking skin biopsies from 25 dogs with different clinical stages of leishmaniosis,
11 with stage I-mild disease (papular dermatitis) and 14 with stage II-III (ulcerative or exfoliative dermatitis).
Results: The study demonstrated microscopic lesions in 14 out of 25 (56%) samples from normal-looking skin biopsies.
In those samples, perivascular to interstitial dermatitis composed by macrophages with lymphocytes and plasma cells
was observed mainly in the superficial and mid-dermis. The intensity of the dermatitis was mild to moderate and always
less prominent than in the clinically-lesioned skin. In normal-looking skin samples, the presence of parasites was detected
by histology, IHC and qPCR in 5/25 (20%), 8/25 (32%) and 18/25 (72%), respectively. Leishmania was encountered in 11/25
(44%), 23/25 (92%) and 25/25 (100%) of clinically-lesioned skin samples by histology, IHC and qPCR, respectively. Normal-
looking skin from dogs with stage I-mild disease was less frequently inflamed (P = 0.0172). Furthermore, Leishmania was
more easily demonstrated by histology (P = 0.0464), IHC (P = 0.0421) or qPCR (P = 0.0068) in normal-looking skin of dogs
with stage II-III-moderate to severe disease. In addition, in the latter group, there was a significantly higher parasite load
studied by means of qPCR than in dogs with less severe disease (P = 0.043). Clinically-lesioned skin from dogs with stage I
disease was more frequently characterised by the nodular to diffuse pattern and granuloma formation (P = 0.0166) and by
a lower parasite load studied by means of qPCR (P = 0.043) compared with more diseased dogs.
Conclusions: Normal-looking skin from dogs with stage I is less likely to present histological lesions as well as harbour
the parasite when compared with dogs with moderate to severe leishmaniosis.
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Background
Canine leishmaniosis (CanL) caused by Leishmania
infantum is a zoonotic vector-borne disease with a wide
geographical distribution in both the Old and New
World. Infected dogs are the main domestic reservoir of
the parasite [1]. Dogs can manifest a chronic subclinical
infection, self-limiting disease, or non-self-limiting ill-
ness [1, 2] as previously documented in humans [3].
Therefore, several degrees of disease severity are found
in dogs ranging from mild disease to severe fatal disease.
Two clinical staging systems are currently used in the
clinical setting [2, 4]. LeishVet clinical staging system
ranges from stage I-mild disease to stage IV-very severe
disease with different clinical outcomes, prognosis and
treatment options [2].
Cutaneous lesions are the most common clinical signs
in CanL [5] and they are very pleomorphic from a clin-
ical and histopathological point of view as well [6]. The
most common dermatological signs observed in dogs
with leishmaniosis include exfoliative dermatitis, ulcera-
tive dermatitis and onychogryphosis [5]. However, other
less typical manifestations such as papular dermatitis,
muco-cutaneous nodular dermatitis or sterile pustular
dermatitis are also diagnosed [5, 6]. This clinical variation
is due to a wide variety of pathological mechanisms occur-
ring secondarily to the inflammation, immune complex
deposition and/or autoantibody production [7] and to
the genetically determined or acquired inability of the
immune system to control parasite multiplication and
tissue invasion [8].
Among the cutaneous manifestations of CanL, papular
dermatitis is the only permissible dermatologic manifest-
ation in stage I leishmaniosis [2]. Dogs with papular
dermatitis commonly show no other clinico-pathological
abnormalities and anti-Leishmania antibodies are nega-
tive or weakly positive. This dermatological problem is
associated with a good specific cell-mediated immune
response as well as the spontaneous resolution of the
lesions within 3–5 months in some cases [9–11].
The normal-looking skin has been scarcely studied ei-
ther in diseased or in infected but clinically healthy dogs
[12–15]. However, only one study evaluated both
clinically-lesioned and normal-looking skin from the same
individuals [14]. In addition, to the best of our knowledge,
comparative studies between paired clinically-lesioned and
normal-looking skin samples from dogs with different
stages of disease severity are lacking. Normal-looking skin
of dogs with leishmaniosis, with or without dermatological
manifestations, frequently shows microscopic lesions
along with the presence of Leishmania amastigotes [5].
However, this might not apply in less severe clinical cases.
The objective of this study was to characterise and
compare the inflammatory pattern and the parasite bur-
den by microscopic examination, immunohistochemistry
(IHC) and real-time polymerase chain reaction (qPCR)
analysis in paired clinically-lesioned and normal-looking
skin from the same dogs with dermatological manifesta-
tions due to CanL with different stages of disease sever-
ity (stage I-mild disease versus stage II-III-moderate to
severe disease).
Methods
Dogs and diagnosis of leishmaniosis
Twenty-five dogs with CanL and dermatological manifest-
ation were prospectively enrolled at the time of diagnosis
from January 2014 to February 2016. The dogs were from
different Catalonian and Balearic veterinary centers from
Spain: Fundació Hospital Clínic Veterinari (Bellaterra,
Barcelona), Hospital Ars Veterinaria (Barcelona), Hospital
Mediterrani Veterinaris (Reus, Tarragona), Consultori
Montsant (Falset, Tarragona) and Hospital Mon Veterinari
(Manacor, Mallorca). The diagnosis of canine leishmanio-
sis was made based on the results of the physical examin-
ation and cytological or dermatopathological examination
of cutaneous lesions. Moreover, a complete blood count
using System Siemens Advia 120 (Siemens Healthcare
GmbH, Germany), a biochemical profile including creatin-
ine, urea, total proteins, alanine transaminase and total
cholesterol by Analyzer Olympus AU 400 (Olympus,
Center Valley, USA), serum protein electrophoresis by
Hydrasys® (Sebia Electrophoresis, Lisses, France), urinaly-
sis with urinary protein/creatinine ratio and quantitative
serology for the detection of L. infantum specific anti-
bodies by means of a serial dilution in-house ELISA were
performed [16, 17]. Dogs were classified in four different
stages (stage I-mild disease, II-moderate disease, III-severe
disease and IV-very severe disease) at the time of diagnosis
as previously described [2].
Collection and processing of skin samples
Two skin fragments from paired clinically-lesioned and
normal-looking skin were collected from each dog.
Normal-looking skin was obtained whenever possible
from the lateral aspect of the neck. In cases where this
region was affected, normal-looking skin was collected
as far away as possible from the macroscopic lesions.
Each skin sample was then immediately cut into two
halves. One half was fixed in 10% formalin for routine
histological and immunohistochemical examination and
the other one submerged in RNA later (RNAlater®
Stabilization Solution, Ambion, Inc., Austin, Texas) and
kept at -80 °C until used for RNA extraction and con-
secutively DNA purification for qPCR analysis.
Histological examination and Leishmania
immunohistochemistry
The dermal inflammatory pattern and the cell popula-
tion were evaluated histologically in haematoxylin and
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eosin (HE)-stained sections. The distribution pattern of
the infiltrate (perivascular to interstitial or nodular to
diffuse with or without granuloma formation); the in-
flammatory cells (macrophages, lymphocytes, plasma
cells and neutrophils); the degree (none, mild, moderate
and severe) of cellular infiltration in the dermis and the
epidermal changes (hyperplasia, spongiosis and exocyt-
osis) were evaluated as previously described [18].
IHC for the detection of L. infantum amastigotes
was performed as previously described [18]. The para-
site load in immunolabelled sections was determined
as the average number of microorganisms counted in
five high power fields of areas with inflammatory in-
filtrate: 0, no microorganisms; 1, 1–10; 2, 11–30; and
3, > 30 [12].
qPCR
RNA was isolated from skin biopsies using the RiboPure
Kit (Ambion, Inc., Austin, Texas) and stored at −80 °C
until used for future studies. DNA was purified from the
interphase and organic phase generated from the RNA
purification process by means of QIAamp DNA Mini
Kit (Qiagen, Manchester, UK) following the manufactur-
er's instructions with slight modifications. Briefly, 20 μl
of proteinase K solution and 200 μl of tissue sample
were used in all cases. The other steps were performed
as per manufacturer's protocol. A fragment of spleen
and/or skin from a clinically healthy non-infected dog
from a non-endemic area (United Kingdom) was used as a
control for DNA contamination during DNA extraction.
qPCR was performed with a relative quantification as
previously described with minor modifications [19].
Briefly, PCR mix reaction was prepared with 4 μl of
DNA, 10 μl of master mix (TaqMan® Fast Advanced Mas-
ter Mix, Thermo Fisher Scientific Inc.), 1 μl of Leishmania
primers and probes (Custom TaqMan® Gene Expression
Assay, ThermoFisher Scientific Inc., Waltham, USA) or
1 μl of another type of assay primers and probes
[Eukaryotic 18S rRNA Endogenous Control (VIC™ ⁄ MGB
Probe, Primer Limited, ThermoFisher Scientific Inc.,
Waltham, USA)] and 5 μl of H2O.
In order to verify that the PCR was done successfully,
a positive control for Leishmania and a negative control
from a non-infected clinically healthy dog were included
in the plate. PCR was carried out in a QuantStudio Flex™
7 Real-Time PCR system (ThermoFisher Scientific Inc.,
Waltham, USA). Thermal cycling profile consisted of
50 °C for 2 min in order to activate the enzyme called
amperase and afterwards, a total of 40 cycles were car-
ried out. Each cycle comprised 20 s at 95 °C followed by
40 cycles of 1 s at 95 °C and 20 s at 60 °C. To compen-
sate for variations in total DNA input, mean values of
cycle threshold (CT) from duplicate determinations
from the Leishmania and 18S rRNA-PCR were taken for
the calculation of the delta CT (difference of expression
between Leishmania CT-18S rRNA CT).
Statistical analysis
The statistical analysis was performed using the SPSS 22.0
for Windows software (SPSS Inc., USA). Categorical data
were expressed as percentage and statistical analysis was
performed using the McNemar's test and Fisher’s exact
test to compare results among related or independent
variables, respectively. Quantitative data were expressed as
means and standard deviations and a non-parametric
Wilcoxon signed-rank test and Mann-Whitney U-test
were used to compare results among related or independ-
ent variables, respectively. Differences were considered
significant with a 5% significance level (P < 0.05).
Results
Description of clinical data of dogs
Both sexes were represented by 11 females and 14 males.
The median age was 2.5 years with a range from five
months to 10 years. Eleven purebred dogs belonging to
ten breeds and 14 mixed-breed dogs were included. Dogs
were classified in three clinical stages: stage I-mild disease
characterised by persistent papular dermatitis (11 dogs,
six females and five males, median age 10 months), II-
moderate disease (12 dogs, three females and nine males,
median age 54 months) and III-severe disease (two female
dogs, median age 54.5 months). For comparative analysis
dogs were divided into two groups: group A (11 dogs with
stage I) and group B (14 dogs with stage II and III). Age
difference was statistically significant among groups
(Mann-Whitney U-test, Z = -2.773, P = 0.006). In group A,
six dogs were serologically negative, three were low
positive and two medium positive, whereas in group
B one was low positive, one was medium positive and
12 were high positive. Moreover, dogs from group A
had significantly lower levels of Leishmania antibodies
(136.8 ± 196.1 ELISA units, EU) than dogs from group B




The prevalence of microscopic lesions and presence of
Leishmania by means of HE in normal-looking skin
samples are shown in Table 1. The epidermis was nor-
mal in all cases but one, with epidermal hyperplasia and
ulceration. This case also showed moderate inflamma-
tory infiltrate in the dermis with amastigotes visible with
HE-stained sections. The inflammatory pattern observed
ranged from perivascular to interstitial mainly in the
superficial and mid-dermis in all cases (Fig. 1). The in-
tensity of the dermatitis was mild to moderate in all
cases where inflammation was present. Macrophages
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with lymphocytes and plasma cells were the predomin-
ant cells. In normal-looking skin samples, the detection
of intramacrophagic structures compatible with amas-
tigotes was demonstrated in 5/25 (20%) samples, all
of them from dogs from group B (Fisher’s exact test,
P = 0.0464) (Fig. 2).
Clinically-lesioned skin
The prevalence of microscopic lesions and detection of
Leishmania by means of HE in clinically-lesioned samples
are shown in Table 1. The most common epidermal
changes were hyperplasia (20/25), followed by ulceration
(8/25) and hyperkeratosis (7/25). Only two samples had
normal epidermis. Moderate to severe lympho-plasmacytic
and macrophagic infiltrates were noted in the dermis of all
patients together with few neutrophils in some patients.
The inflammatory pattern observed was nodular to diffuse
in 13 samples (nine from group A and four from group B)
and perivascular to interstitial in 12 clinically-lesioned
samples (two from group A and ten from group B). There-
fore, skin samples from group A were more frequently
characterised by a nodular to diffuse pattern than skin
samples from group B (Fisher’s exact test, P = 0.0154).
Granulomas were only observed in four samples, all of
them from group A (Fisher’s exact test, P = 0.0166) (Fig. 3).
Amastigotes compatible with Leishmania were noted in
11/25 (44%) samples. Most of these (10/11) were samples
from group B and this difference was statistically signifi-
cant (Fisher’s exact test, P = 0.0037).
Leishmania immunohistochemistry
The prevalence of positive IHC in clinically-lesioned and
normal-looking skin samples are shown in Table 1. Amas-
tigotes were noted in 8/25 (32%) normal-looking skin
samples. Seven out eight of these samples were from dogs
Table 1 Frequency of microscopic lesions and detection of Leishmania by means of HE, IHC and qPCR on paired skin samples from





Normal-looking skin (n = 25) 14/25 (56.0 %) 5/25 (20%) 8/25 (32.0%) 18/25 (72.0%)
Stage I (n = 11) 3/11 (27.3%)a,b 0/11 (0%)c 1/11 (9.1%)d 5/11 (45.5%)e
Stage II-III (n = 14) 11/14 (78.6%)b 5/14 (35.7%)c 7/14 (50.0%)d 13/14 (92.9%)e
Clinically-lesioned skin (n = 25) 25/25 (100%) 11/25 (44.0%) 23/25 (92.0%) 25/25 (100%)
Stage I (n = 11) 11/11 (100%)a 1/11 (9.1%)f 9/11 (81.8%) 11/11 (100%)
Stage II-III (n = 14) 14/14 (100%) 10/14 (71.4%)f 14/14 (100%) 14/14 (100%)
Abbreviations: HE haematoxylin and eosin stained sections, IHC Leishmania immunohistochemistry, qPCR quantitative PCR
aMcNemar's test: P = 0.008
bFisher’s exact test: P = 0.0172
cFisher’s exact test: P = 0.0464
dFisher’s exact test: P = 0.0421
eFisher’s exact test: P = 0.0068
fFisher’s exact test: P = 0.0037
Fig. 1 Superficial and mid perivascular to interstitial dermatitis in
normal-looking skin from a dog with stage II leishmaniosis (haematoxylin
and eosin staining)
Fig. 2 Numerous intracellular Leishmania amastigotes in macrophages
(arrows) from the inflammatory infiltrate present in the dermis of
normal-looking skin sample from a dog with stage II leishmaniosis
(haematoxylin and eosin staining)
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from group B (Fisher’s exact test, P = 0.0421; Fig. 4). The
majority of positive samples (6/8) had few amastigotes
(1–10 per high power field) with one between 11–30
and another with more than 30 per high power field.
On the other hand, amastigotes were noted in 23/25
(92%) clinically-lesioned skin samples. Two samples with
negative IHC were from dogs from group A. Although
marginally statistically significant, there was a trend for a
higher parasite load in clinically-lesioned skin from dogs
from group B compared with group A (Mann-Whitney
U-test: Z = -1,943, P = 0.052; Fig. 5; Table 2).
qPCR
The normal-looking skin of 18/25 (72%) dogs studied
was qPCR positive for Leishmania (Table 1). Negative
qPCR was almost always associated with a microscopic-
ally normal skin. Only one dog presented mild perivas-
cular dermatitis in the deep dermis and qPCR was
negative. From 11 samples without histological lesions,
five resulted qPCR positive. The prevalence of negative
qPCR on normal-looking skin samples from dogs from
group A was higher than that detected in normal-
looking skin from dogs from group B (Fisher’s exact test,
P = 0.0068). The parasite load studied by means of qPCR
in normal-looking skin samples was always lower than in
clinically-lesioned skin whatever the stage of disease
Fig. 3 Nodular to diffuse dermatitis with granuloma formation in
clinically-lesioned skin from a dog with stage I leishmaniosis
(haematoxylin and eosin staining)
Fig. 4 Few (1–10 per high power field) intracellular Leishmania
amastigotes (arrows) are visualized in macrophages from the
inflammatory infiltrate present in the dermis of normal-looking skin
sample from the same dog as in Fig. 1 (Leishmania-specific IHC staining)
Fig. 5 Note only one intracellular Leishmania amastigote (arrow) in
the center of a granuloma in the inflammatory infiltrate present in
the dermis of clinically-lesioned skin from the same dog as in Fig. 3
(Leishmania-specific IHC staining)
Table 2 Parasite load by means of Leishmania-specific IHC and






Normal-looking skin (n = 25) 0.4 ± 0.8b 3.0 ± 4.7h
Stage I (n = 11) 0.1 ± 0.3c,d 6.1 ± 4.0i,j
Stage II-III (n = 14) 0.5 ± 0.7d,e 1.7 ± 4.5j,k
Clinically-lesioned skin (n = 25) 1.5 ± 0.9b 1.5 ± 4.9h
Stage I (n = 11) 1.1 ± 0.8c,f 3.4 ± 4.4i,l
Stage II-III (n = 14) 1.7 ± 0.9e,f -0.4 ± 4.7k,l
Abbreviations: qPCR, quantitative PCR IHC Leishmania immunohistochemistry,
SD standard deviation
aFor method of grading, see Methods
bWilcoxon Signed-rank test: Z = -4.345, P < 0.0001
cWilcoxon Signed-rank test: Z = -2.887, P = 0.004
dMann-Whitney U-test: Z = -2.169, P = 0.03
eWilcoxon Signed-rank test: Z = -3.274, P = 0.001
fMann-Whitney U-test: Z = -1.943, P = 0.052
gDelta CT (difference of expression between Leishmania CT -18S CT)
hWilcoxon Signed-rank test: Z = -3.332, P = 0.001
iWilcoxon Signed-rank test: Z = -2.023, P = 0.043
jMann-Whitney U-test: Z = -2.021, P = 0.043
kWilcoxon Signed-rank test: Z = -2.691, P = 0.007
lMann-Whitney U-test: Z = -2.026, P = 0.043
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(Wilcoxon signed-rank test, group A: Z = -2.023, P = 0.043;
group B: Z = -2.691, P = 0.007; Table 2). The relative
amounts of parasites in normal-looking skin from
dogs from group A was lower than in normal-looking
skin from dogs from group B (Mann-Whitney U-test:
Z = -2.021, P = 0.043; Table 2).
As expected, 25/25 (100%) of clinically-lesioned skin were
qPCR positive and the parasite load was higher in samples
from dogs from group B compared with dogs from group
A (Mann-Whitney U-test: Z = -2.026, P = 0.043, Table 2).
Discussion
In this study, we demonstrated histological and parasite
load differences not only among clinically-lesioned and
normal-looking skin of the same dogs but also among
skin samples of dogs with different clinical stages of
leishmaniosis.
In agreement with previous studies, we demonstrated
that the normal-looking skin of dogs with leishmaniosis
frequently shows microscopic lesions (56%) and harbours
the parasite, as demonstrated by routine HE staining
(20%), Leishmania-specific IHC (32%) and, more often, by
qPCR (72%). However, there are some differences among
our results and those previously reported [12–15]. The
prevalence of microscopic lesions and detection of amasti-
gotes either by routine histology or by IHC in our study
was at the lower limit of the ranges reported in previ-
ous studies. Microscopic lesions have been noticed in
50–100% of the skin samples obtained from the
normal-looking skin of dogs with CanL [5, 12–14].
Moreover, amastigotes were seen in up to 100% of
the cases, depending on the sensitivity of the method
employed [5]. These findings are probably related to
the fact that in the present study about half of the
dogs had mild disease, i.e. papular dermatitis. Con-
versely, previous studies included either dogs with
more severe disease, i.e. exfoliative dermatitis [14] or
even stray dogs, which could present co-factors, such
as co-infections or malnutrition, affecting the severity
of disease [12, 13].
In the present study, we demonstrated that dogs
with different clinical stages of leishmaniosis pre-
sented differences in the frequency of microscopic le-
sions and parasite load in normal-looking skin. The
skin biopsies from normal-looking skin from dogs
with stage I-mild disease (papular dermatitis) were
significantly less frequently inflamed. Furthermore,
Leishmania was more frequently demonstrated by
routine histology, immunohistochemical examination
or qPCR in normal-looking skin of dogs with stage
II-III-moderate to severe disease. In addition, in the
latter group, there was a significantly higher parasite
load studied by means of qPCR than in dogs with less
severe disease. These results suggest that dermal
inflammation and cutaneous parasitism in normal-
looking skin were directly related to the severity of
clinical disease. Normal-looking skin of dogs with
stage I-mild disease may resemble the skin of sero-
negative infected but clinically healthy dogs that is
characterized by no histological lesions and absence
of parasites by IHC, although their presence can be
demonstrated by PCR [12].
Microscopic lesions and presence of amastigotes in the
inflammatory infiltrate in normal-looking skin of dis-
eased dogs is suggestive of haematogenous dissemin-
ation of the parasite and tropism for the skin [12].
Moreover, it has been demonstrated that dissemination
to the skin varies between dogs, being greater in sick
and infectious dogs [20]. Therefore, lack of these
changes in the majority of dogs with normal-looking
skin with stage I-mild disease would further suggest a
protective immune response in these dogs able to con-
trol parasite dissemination at the site of parasite inocula-
tion and multiplication as previously proposed [11, 18].
Histological findings observed in clinically-lesioned
skin of dogs included in this study were in accordance
with the literature [5, 6, 18] and amastigotes were vari-
ably seen in 44 and 92% of the cases, depending on the
method employed. However, the results of this study fur-
ther confirm that skin biopsies from dogs with papular
dermatitis (stage I-mild disease) are characterised by the
nodular to diffuse pattern and a significant higher fre-
quency of granuloma formation compared with more
severe cutaneous manifestation of CanL (stage II–III-
moderate or severe disease) [18]. It has been proposed
previously that there is a trend for a lower parasite bur-
den in skin samples from dogs with stage I-mild disease
[18]. Although amastigotes were more frequently noted
in HE stained slides from stage II-III diseased dogs when
compared with stage I dogs, there were no statistically
significant differences in prevalence between positive IHC
or qPCR among both groups studied. Nevertheless, the
parasite load studied by means of qPCR was lower in sam-
ples from dogs with stage I-mild disease compared with
dogs with severe disease. Taken together, these data might
reinforce the idea of a protective immune response that
these dogs have as described elsewhere [10, 11, 18].
Several studies have focused on the capacity of dogs to
infect phlebotomine sand flies. It has been reported that
the proportion of infected sand flies increases with the
appearance and severity of the clinical signs and that
good predictors of infectiousness are antibody levels and
clinical disease, since no dogs have been found to be in-
fectious before the detection of anti-Leishmania IgG
antibodies [21, 22]. Moreover, it has been recently sug-
gested that high parasite loads in dog ear skin, rather
than the simple presence of parasites, is the most im-
portant metric to identify likely infectious individuals
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and potential reservoir populations [20]. Therefore, the
fact that dogs with stage I-mild disease or papular
dermatitis are characterised by reduced parasite load in
both normal-looking skin and clinically-lesioned skin,
emphasizes the concept that these dogs do not play a
significant role in L. infantum infection of phlebotomine
sand flies as opposed to dogs with stage II-III disease.
Conclusions
In conclusion, this study confirms that normal-looking
skin from dogs with stage I is less likely to present
microscopic lesions as well as harbour the parasite when
compared with dogs with moderate to severe CanL.
Moreover, clinically-lesioned skin from dogs with stage I
shows a lower parasite load than clinically-lesioned skin
from more diseased dogs.
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